Japan

JPY overview

PairLatest rateToday's change1 year change
JPYGBP0.007
GBP
0.000001 / 0.01%0.00004 / 0.61%
Today
0.0069Feb 21 20200.0081Mar 18 2020
JPYEUR0.0079
EUR
0.00002 / 0.23%-0.0004 / -4.44%
Today
0.0078Jan 07 20210.0087May 06 2020
JPYUSD0.0096
USD
0.000002 / 0.02%0.0005 / 5.27%
Today
0.0089Feb 20 20200.0099Mar 09 2020
JPYAUD0.0125
AUD
-0.00001 / -0.11%-0.0009 / -6.97%
Today
0.0124Jan 08 20210.0167Mar 19 2020
JPYCAD0.0123
CAD
-0.000009 / -0.07%0.0002 / 1.85%
Today
0.0118Feb 20 20200.0135Mar 18 2020
JPYCNY0.0624
CNY
-0.00003 / -0.05%-0.0011 / -1.71%
Today
0.0619Jan 12 20210.0687Mar 09 2020
JPYCHF0.0086
CHF
0.00002 / 0.28%-0.0003 / -3.80%
Today
0.0085Aug 28 20200.0092May 07 2020

Equity fund country flows

This chart shows the cumulative weekly equity in country flows into or out of Japan in USD. EPFR Global provides global coverage of foreign investor flows, tracking over 15,000 funds domiciled around the world.
As of Dec 16 2020.

Market movers

Constituents of the Nikkei 225 with the highest percent gain over one day.
ListingLastChangeVolume
Alps Alpine Co Ltd6770:TYO1,543.00
JPY
+89.00
+6.12%
4.51m
Sumitomo Chemical Co Ltd4005:TYO500.00
JPY
+27.00
+5.71%
21.77m
Asahi Kasei Corp3407:TYO1,204.50
JPY
+60.00
+5.24%
5.77m
Ube Industries Ltd4208:TYO2,038.00
JPY
+101.00
+5.21%
1.09m
Nikon Corp7731:TYO855.00
JPY
+42.00
+5.17%
7.68m
Kyowa Kirin Co Ltd4151:TYO2,918.00
JPY
+140.00
+5.04%
882.10k
M3 Inc2413:TYO10,565.00
JPY
+415.00
+4.09%
2.86m
Mitsubishi Chemical Holdings Corp4188:TYO746.00
JPY
+26.00
+3.61%
13.64m
Takeda Pharmaceutical Co Ltd4502:TYO3,714.00
JPY
+127.00
+3.54%
10.05m
DIC Corp4631:TYO2,610.00
JPY
+87.00
+3.45%
325.30k
Data delayed at least 15 minutes, as of Jan 25 2021 06:00 GMT.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.